Gian Marco Ghiggeri

21.9k total citations · 1 hit paper
359 papers, 12.0k citations indexed

About

Gian Marco Ghiggeri is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Gian Marco Ghiggeri has authored 359 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Nephrology, 136 papers in Molecular Biology and 54 papers in Pathology and Forensic Medicine. Recurrent topics in Gian Marco Ghiggeri's work include Renal Diseases and Glomerulopathies (150 papers), Chronic Kidney Disease and Diabetes (55 papers) and Autoimmune Bullous Skin Diseases (38 papers). Gian Marco Ghiggeri is often cited by papers focused on Renal Diseases and Glomerulopathies (150 papers), Chronic Kidney Disease and Diabetes (55 papers) and Autoimmune Bullous Skin Diseases (38 papers). Gian Marco Ghiggeri collaborates with scholars based in Italy, United States and Canada. Gian Marco Ghiggeri's co-authors include Giovanni Candiano, Maurizio Bruschi, Laura Santucci, Gianluca Caridi, Luca Musante, Francesco Scolari, Pier Giorgio Righetti, Paola Orecchia, Barbara Carnemolla and Luciano Zardi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Gian Marco Ghiggeri

349 papers receiving 11.8k citations

Hit Papers

Blue silver: A very sensi... 2004 2026 2011 2018 2004 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gian Marco Ghiggeri Italy 55 5.2k 5.0k 1.7k 1.7k 1.5k 359 12.0k
Moin A. Saleem United Kingdom 67 7.8k 1.5× 5.8k 1.2× 1.1k 0.6× 1.4k 0.8× 1.7k 1.1× 324 14.4k
Yashpal S. Kanwar United States 59 3.7k 0.7× 6.3k 1.3× 1.0k 0.6× 882 0.5× 1.6k 1.0× 234 13.8k
Keith A. Hruska United States 68 5.3k 1.0× 7.1k 1.4× 1.5k 0.9× 1.7k 1.0× 643 0.4× 269 15.2k
Jochen Reiser United States 51 9.1k 1.8× 5.3k 1.1× 944 0.6× 1.5k 0.9× 1.7k 1.2× 179 14.1k
David J. Nikolic‐Paterson Australia 70 6.0k 1.2× 5.9k 1.2× 2.2k 1.3× 1.2k 0.7× 4.7k 3.1× 244 17.6k
Gerhard A. Müller Germany 52 2.9k 0.6× 3.5k 0.7× 1.4k 0.8× 739 0.4× 1.3k 0.9× 302 10.5k
Lambertus P. van den Heuvel Netherlands 54 1.8k 0.4× 4.3k 0.9× 741 0.4× 1.3k 0.8× 1.4k 0.9× 257 10.3k
Jeremy Hughes United Kingdom 45 3.0k 0.6× 2.8k 0.6× 1.3k 0.8× 1.0k 0.6× 2.3k 1.5× 112 8.8k
P Verroust France 55 2.1k 0.4× 3.5k 0.7× 738 0.4× 1.1k 0.6× 1.1k 0.7× 163 8.5k
L.A.H. Monnens Netherlands 48 1.8k 0.3× 3.7k 0.8× 1.5k 0.9× 715 0.4× 1.1k 0.7× 275 8.7k

Countries citing papers authored by Gian Marco Ghiggeri

Since Specialization
Citations

This map shows the geographic impact of Gian Marco Ghiggeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Marco Ghiggeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Marco Ghiggeri more than expected).

Fields of papers citing papers by Gian Marco Ghiggeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gian Marco Ghiggeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Marco Ghiggeri. The network helps show where Gian Marco Ghiggeri may publish in the future.

Co-authorship network of co-authors of Gian Marco Ghiggeri

This figure shows the co-authorship network connecting the top 25 collaborators of Gian Marco Ghiggeri. A scholar is included among the top collaborators of Gian Marco Ghiggeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Marco Ghiggeri. Gian Marco Ghiggeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caridi, Gianluca, Sonia Spinelli, Francesca Lugani, et al.. (2025). The Crosstalk Between NETs and the Complement Cascade: An Overview in Nephrological Autoimmune Disease. International Journal of Molecular Sciences. 26(6). 2789–2789. 2 indexed citations
2.
Caridi, Gianluca, Alessandro Consolaro, Francesca Lugani, et al.. (2025). Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis. Frontiers in Immunology. 16. 1525892–1525892. 3 indexed citations
3.
Ariceta, Gema, Gian Marco Ghiggeri, Dieter Haffner, et al.. (2024). C3 glomerulopathy in children: a European longitudinal study evaluating outcome. Pediatric Nephrology. 40(4). 979–986. 1 indexed citations
4.
Angeletti, Andrea, Sofia Bin, Alberto Magnasco, et al.. (2023). Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis. American Journal of Transplantation. 24(4). 688–692. 7 indexed citations
5.
Bruschi, Maurizio, Giovanni Candiano, Andrea Petretto, et al.. (2023). #6225 MICROPLASTICS: FIRST EXTENDED PROTEOMIC ANALYSIS ON KIDNEY TUBULAR CELLS. Nephrology Dialysis Transplantation. 38(Supplement_1). 3 indexed citations
6.
Delbarba, Elisa, Domenico Santoro, Loreto Gesualdo, et al.. (2020). Rituximab vs. Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Trial. Journal of the American Society of Nephrology. 31(10S). B9–B9. 1 indexed citations
7.
Chan, Eugene Yu-hin, Hazel Webb, E. Yu, et al.. (2019). Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Kidney International. 97(2). 393–401. 66 indexed citations
8.
Ravani, Pietro, Alice Bonanni, & Gian Marco Ghiggeri. (2017). Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol. BMJ Open. 7(3). e013319–e013319. 22 indexed citations
9.
Radice, Antonella, Federico Pieruzzi, Barbara Trezzi, et al.. (2017). Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Journal of Nephrology. 31(2). 271–278. 55 indexed citations
10.
Ghiggeri, Gian Marco, Maddalena Gigante, & Armando Di Donato. (2013). Constitutional Nephrin Deficiency in Conditionally Immortalized Human Podocytes Induced Epithelial-Mesenchymal Transition, Supported byβ-Catenin/NF-kappa B Activation: A Consequence of Cell Junction Impairment?. International Journal of Nephrology. 2013. 1–15. 11 indexed citations
11.
Mattioli, Girolamo, et al.. (2012). Intraureteral Injection of NASHA/Dx Gel Under Direct Ureteroscopic Visualization for the Treatment of Primary High-Grade Vesicoureteral Reflux. Journal of Laparoendoscopic & Advanced Surgical Techniques. 22(8). 844–847. 2 indexed citations
12.
Prunotto, Marco, Maria Luisa Carnevali, Giovanni Candiano, et al.. (2010). Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2. Journal of the American Society of Nephrology. 21(3). 507–519. 166 indexed citations
13.
Musante, Luca, Giovanni Candiano, Andrea Petretto, et al.. (2007). Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin. Journal of the American Society of Nephrology. 18(3). 799–810. 65 indexed citations
14.
Izzi, Claudia, Pietro Ravani, Diletta Domenica Torres, et al.. (2006). IgA Nephropathy: The Presence of Familial Disease Does Not Confer an Increased Risk for Progression. American Journal of Kidney Diseases. 47(5). 761–769. 22 indexed citations
15.
Caridi, Gianluca, Monica Dagnino, Andrea Rossi, et al.. (2006). Nephronophthisis type 1 deletion syndrome with neurological symptoms: Prevalence and significance of the association. Kidney International. 70(7). 1342–1347. 28 indexed citations
16.
Ghiggeri, Gian Marco, Filippo Aucella, Gianluca Caridi, et al.. (2006). Posttransplant Recurrence of Proteinuria in a Case of Focal Segmental Glomerulosclerosis Associated with WT1 Mutation. American Journal of Transplantation. 6(9). 2208–2211. 13 indexed citations
17.
Candiano, Giovanni, Luca Musante, Maurizio Bruschi, et al.. (2006). Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome. Journal of the American Society of Nephrology. 17(11). 3139–3148. 111 indexed citations
18.
Gusmano, R, Gianna Mazzucco, Guido Monga, & Gian Marco Ghiggeri. (2004). Focal and segmental glomerulosclerosis (FSGS). Clinical, morphological and genetic features. Journal of Nephrology. 17(1). 139–157. 1 indexed citations
19.
Scolari, Francesco, Battista Fabio Viola, Gian Marco Ghiggeri, et al.. (2003). Towards the identification of (a) gene(s) for autosomal dominant medullary cystic kidney disease. Journal of Nephrology. 16(3). 321–328. 8 indexed citations
20.
Candiano, Giovanni, et al.. (1990). Analysis of albumin charge by direct immunofixation in ultrathin gels. Kidney International. 37(3). 1002–1005. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026